University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Efficacy and safety of triazavirin therapy for coronavirus disease 2019 : A pilot randomized controlled trial

dc.contributor.authorWu, Xiaoke
dc.contributor.authorYu, Kaijiang
dc.contributor.authorWang, Yongchen
dc.contributor.authorXu, Wanhai
dc.contributor.authorMa, Hongli
dc.contributor.authorHou, Yan
dc.contributor.authorLi, Yue
dc.contributor.authorCai, Benzhi
dc.contributor.authorZhu, Liying
dc.contributor.authorZhang, Min
dc.contributor.authorHu, Xiaoli
dc.contributor.authorGao, Jingshu
dc.contributor.authorWang, Yu
dc.contributor.authorQin, Huichao
dc.contributor.authorWang, Wenjie
dc.contributor.authorZhao, Mingyan
dc.contributor.authorWu, Xia
dc.contributor.authorZhang, Yong
dc.contributor.authorLi, Lu
dc.contributor.authorLi, Kang
dc.contributor.authorDu, Zhimin
dc.contributor.authorMol, Ben Willem J
dc.contributor.authorYang, Baofeng
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Women’s Health Researchen
dc.date.accessioned2021-04-02T12:56:01Z
dc.date.available2021-04-02T12:56:01Z
dc.date.issued2020-10
dc.descriptionAcknowledgements: We are deeply grateful to the front-line clinicians who participated in the study while directly fighting the epidemic. This study was supported by the Chinese Academy of Engineering Projects for COVID-19 (2020-KYGG-01-04) and Heilongjiang Province Urgent Project-6 for COVID-19. Data and safety monitoring board members of this trial included Kang Li, Yong Zhang, Songjiang Liu, and Yaohui Shi.en
dc.description.statusPeer revieweden
dc.format.extent7
dc.format.extent709031
dc.identifier176213645
dc.identifierb9506c66-7a93-4df0-be3b-81187459b66d
dc.identifier32923016
dc.identifier85091712049
dc.identifier.citationWu, X, Yu, K, Wang, Y, Xu, W, Ma, H, Hou, Y, Li, Y, Cai, B, Zhu, L, Zhang, M, Hu, X, Gao, J, Wang, Y, Qin, H, Wang, W, Zhao, M, Wu, X, Zhang, Y, Li, L, Li, K, Du, Z, Mol, B W J & Yang, B 2020, 'Efficacy and safety of triazavirin therapy for coronavirus disease 2019 : A pilot randomized controlled trial', Engineering (Beijing, China), vol. 6, no. 10, pp. 1185-1191. https://doi.org/10.1016/j.eng.2020.08.011en
dc.identifier.doi10.1016/j.eng.2020.08.011
dc.identifier.iss10en
dc.identifier.issn2095-8099
dc.identifier.otherPubMedCentral: PMC7476906
dc.identifier.urihttps://hdl.handle.net/2164/16182
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85091712049&partnerID=8YFLogxKen
dc.identifier.vol6en
dc.language.isoeng
dc.relation.ispartofEngineering (Beijing, China)en
dc.subjectCoronavirus disease 2019en
dc.subjectTriazavirinen
dc.subjectEfficacyen
dc.subjectSafetyen
dc.subjectR Medicineen
dc.subjectGeneral Engineeringen
dc.subjectEnergy Engineering and Power Technologyen
dc.subjectGeneral Chemical Engineeringen
dc.subjectGeneral Computer Scienceen
dc.subjectEnvironmental Engineeringen
dc.subjectMaterials Science (miscellaneous)en
dc.subject.lccRen
dc.titleEfficacy and safety of triazavirin therapy for coronavirus disease 2019 : A pilot randomized controlled trialen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Wu_et_al_Efficacy_Safety_Engineering_vor.pdf
Size:
692.41 KB
Format:
Adobe Portable Document Format

Collections